Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Theravance Biopharma Inc (TBPH)

169 + Investors. Track Smart Money conviction in TBPH. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +2
Streak
6Q ▲
Buyers last Q
56%

Smart Money Signals — TBPH

Based on 170 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 6 quarters in a row

last 6Q
For 6 consecutive quarters, more hedge funds added TBPH than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
170 hedge funds hold TBPH right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +29% more funds vs a year ago

fund count last 6Q
+38 new funds entered over the past year (+29% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 56% buying

100 buying80 selling
Last quarter: 100 funds bought or added vs 80 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+10 vs last Q)

new funds entering per quarter
Funds opening a new TBPH position: 25 → 37 → 28 → 38. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

56% of holders stayed for 2+ years

■ 56% conviction (2yr+) ■ 23% medium ■ 21% new
95 out of 170 hedge funds have held TBPH for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +3%, value -13%

Value
-13%
Shares
+2%
Last quarter: funds added +3% more shares while total portfolio value only changed -13%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~38 new funds/quarter

25 → 25 → 37 → 28 → 38 new funds/Q
New funds entering each quarter: 25 → 37 → 28 → 38. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 68% veterans vs 22% newcomers

■ 68% veterans ■ 10% 1-2yr ■ 22% new
Entry-cohort mix of 176 holders: 120 (68%) are 2+ year veterans, 17 entered 1–2 years ago, and 39 (22%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 20% AUM from major funds

20% from top-100 AUM funds
42 of 169 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TBPH

In 2026 Q1, 100 hedge funds were net buyers of TBPH (38 opened a new position, 62 added to an existing one), while 80 reduced or exited (44 trimmed, 36 sold completely) — a 56% buyer ratio, indicating a slight buying edge. This marks 6 consecutive quarters of net institutional buying — a persistent conviction signal. 20% of total institutional value in TBPH is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +2 funds (more new holders than closures). Total institutional holders: 170.

Hedge Fund Ownership: TBPH

How many hedge funds hold TBPH — quarterly history vs. share price
Quarterly hedge fund ownership of TBPH vs. share price

Market Analysis: TBPH

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TBPH

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Theravance Biopharma Inc (TBPH) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TBPH has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 86d ago
TBPH
+6.7%
XLV
+6.5%

TBPH outperformed XLV by +0.2% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 41d ago
TBPH
+6.7%
XLV
+7.6%

Since the filing became public, TBPH outperformed XLV by -0.9% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

22 top-rated funds 1 high-conviction
Consensus
5.9
/ 10
breadth
×
Elite
2.7
/ 10
conviction
Hedge Fund Positioning: TBPH
169 + Investors

Track Smart Money conviction in TBPH. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 169 168 0.6%
13F Shares 51M 49M 2.65%
Total Value $800M $922M -13.25%
New Positions 37 28 +9
Increased Positions 61 71 -10
Closed Positions 36 19 +17
Reduced Positions 43 48 -5
Total Calls 3 3 -
Total Puts 4 0 100%
PUT/CALL Ratio 1.33 0.0 Bearish

Statistics: TBPH

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

169 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TBPH. Verified SEC 13F-HR filings.

QUARTER:
Top 25 TBPH holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Newtyn Management, LLC 8.40% 4,841,629 $78.6M
2 Madison Avenue Partners, LP 6.71% 9,511,150 $154.4M
3 Irenic Capital Management LP 2.92% 2,760,948 $44.8M
4 Weiss Asset Management LP 2.05% 7,457,060 $121.0M
5 Rangeley Capital, LLC 1.62% 103,000 $1.7M
6 Marble Bar Asset Management LLP 1.36% 85,074 $1.4M
7 Oasis Management Co Ltd. 0.55% 583,490 $9.5M
8 Cannon Global Investment Management, LLC 0.51% 16,047 $260K
9 Precision Wealth Strategies, LLC 0.34% 62,815 $1.0M
10 EntryPoint Capital, LLC 0.24% 49,739 $807K
11 683 Capital Management, LLC 0.21% 250,000 $4.1M
12 Virtus Investment Advisers, LLC 0.21% 46,464 $754K
13 Integrated Quantitative Investments LLC 0.15% 49,709 $807K
14 NJ State Employees Deferred Compensation Plan 0.09% 58,142 $849K
15 Virtus Advisers, LLC 0.07% 9,100 $148K
16 CWA Asset Management Group, LLC 0.05% 94,902 $1.5M
17 Legato Capital Management LLC 0.05% 32,137 $522K
18 State of Wyoming 0.04% 22,007 $357K
19 PDT Partners, LLC 0.03% 33,796 $549K
20 Prelude Capital Management, LLC 0.03% 25,000 $406K
21 James Investment Research, INC. 0.03% 14,833 $241K
22 Martingale Asset Management L P 0.03% 65,926 $1.1M
23 Globeflex Capital L P 0.03% 10,512 $171K
24 Trexquant Investment LP 0.02% 205,784 $3.3M
25 Campbell & CO Investment Adviser LLC 0.02% 25,839 $419K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Theravance Biopharma Inc (TBPH)

What does the Smart Money Trend signal show for TBPH?

Buying streak — 6 quarters in a row: For 6 consecutive quarters, more hedge funds added TBPH than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TBPH?

Slight buying edge — 56% buying: Last quarter: 100 funds bought or added vs 80 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for TBPH holders?

Strong quality — 20% AUM from major funds: 42 of 169 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TBPH?

56% of holders stayed for 2+ years: 95 out of 170 hedge funds have held TBPH for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Theravance Biopharma Inc (TBPH) following the 2026 Q1 hedge fund 13F filings?

As of today, TBPH has moved +6.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +7.6% for the XLV sector ETF — an outperformance of -0.9%. Since the quarter end (March 31, 2026), TBPH has gained +6.7% vs +6.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →